Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03628183 · ClinicalTrials.gov registry record · NA
Tolerance of Infants Fed a Hydrolysate Formula
A NA study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT03628183 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 51 participants.
The verdict
NCT03628183, a NA study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
This is a prospective, randomized, multicenter study to assess the tolerance of infant formulas.
Interventions
- OTHER Hydrolysate Infant Formula 1
- OTHER Hydrolysate Infant Formula 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2018-08-28 |
| Est. Completion | 2018-11-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03628183
The ClinicalTrials.gov registry entry for NCT03628183 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydrolysate Infant Formula 1 is the first listed.
NCT03628183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03628183 about?
NCT03628183 is a clinical study titled "Tolerance of Infants Fed a Hydrolysate Formula". This is a prospective, randomized, multicenter study to assess the tolerance of infant formulas.
What is the current status of trial NCT03628183?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2018-08-28. Estimated completion is 2018-11-23.
What interventions are being tested in trial NCT03628183?
The interventions under investigation include: Hydrolysate Infant Formula 1 (OTHER), Hydrolysate Infant Formula 2 (OTHER).
Who is sponsoring clinical trial NCT03628183?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.